ReviewCurrent diabetes reports2016
The State of Diabetes Prevention Policy in the USA Following the Affordable Care Act.
Review in Current diabetes reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 23 citations in OpenAlex.
- Temporal trends in cardiovascular disease and diabetes prevalence in the United States: assessing compression versus expansion.Scientific reports · 2026Article
- Use of an Electronic Health Record Order to Directly Refer Patients With Prediabetes to Community-Based Diabetes Prevention Programs.Annals of family medicine · 2025Article
- Neighborhood socioeconomic disadvantage and travel time to diabetes prevention programs in Maryland.Health & place · 2025Article
- A mixed-methods, theory-driven assessment of the sustainability of a multi-sectoral preventive intervention for South Asian Americans at risk for cardiovascular disease.Implementation science communications · 2024Article
- External validation and application of the Diabetes Population Risk Tool (DPoRT) for prediction of type 2 diabetes onset in the US population.BMJ open diabetes research & care · 2024Article
- Impact of changes in diabetes screening guidelines on testing eligibility and potential yield among adults without diagnosed diabetes in the United States.Diabetes research and clinical practice · 2023Article
- Income-related inequalities in diagnosed diabetes prevalence among US adults, 2001-2018.PloS one · 2023Article
- Non-communicable diseases are key to further narrow gender gap in life expectancy in Shanghai, China.BMC public health · 2020Article
- Effect on Health Care Expenditures During Nationwide Implementation of the Diabetes Prevention Program as a Health Insurance Benefit.Diabetes care · 2019Article
- Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond.Current diabetes reports · 2019Review
- Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults.Current diabetes reports · 2018Review
- A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort Study.BMC public health · 2016Article
- Screening for Dysglycemia: Connecting Supply and Demand to Slow Growth in Diabetes Incidence.PLoS medicine · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
Type 2 diabetes is a major public health problem in the USA, affecting over 12 % of American adults and imposing considerable health and economic burden on individuals and society. There is a strong evidence base demonstrating that lifestyle behavioral changes and some medications can prevent or delay the onset of type 2 diabetes in high risk adults, and several policy and healthcare system changes motivated by the Patient Protection and Affordable Care Act (ACA) have the potential to accelerate diabetes prevention. In this narrative review, we (1) offer a conceptual framework for organizing how the ACA may influence diabetes prevention efforts at the level of individuals, healthcare providers, and health systems; (2) highlight ACA provisions at each of these levels that could accelerate type 2 diabetes prevention nationwide; and (3) explore possible policy gaps and opportunity areas for future research and action.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.